Accelerated development of chronic lymphocytic leukemia in New Zealand black mice expressing a low level of interferon regulatory factor 4

Journal of Biological Chemistry

Volumn 288, Issue 37, 2013, Pages 26430-26440

  Ma, Shibin ^a   Shukla, Vipul ^a   Fang, Leilei ^a   Gould, Karen A ^a   Joshi, Shantaram S ^a   Lu, Runqing ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; CAUSAL RELATIONSHIPS; CHRONIC LYMPHOCYTIC LEUKEMIAS; CLL CELLS; LEVEL OF INTERFERONS; NEW ZEALAND; SNP ASSOCIATION STUDIES;

BIOCHEMISTRY;

BIOLOGY;

B LYMPHOCYTE RECEPTOR; INTERFERON REGULATORY FACTOR 4; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CANCER GROWTH; CELL RENEWAL; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA BINDING MOTIF; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION REGULATION; HETEROZYGOTE; HISTOPATHOLOGY; IRF4 GENE; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

CLL; GENETIC POLYMORPHISM; IRF; IRF4; LEUKEMIA; LYMPHOCYTE; NZB; SNP; TRANSCRIPTION FACTORS; TUMOR CELL BIOLOGY;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENOME-WIDE ASSOCIATION STUDY; HETEROZYGOTE; HOMEOSTASIS; HUMANS; INTERFERON REGULATORY FACTORS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICE; MICE, INBRED NZB; MICE, TRANSGENIC; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPLEEN;

EID: 84884184071     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.475913     Document Type: Article

References (52)

1. Dighiero, G., and Hamblin, T. J. (2008) Chronic lymphocytic leukaemia. Lancet 371, 1017-1029
2. Gaidano, G., Foà, R., and Dalla-Favera, R. (2012) Molecular pathogenesis of chronic lymphocytic leukemia. J. Clin. Invest. 122, 3432-3438
3. Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q., Mo, T., Ambesi-Impiombato, A., Califano, A., Migliazza, A., Bhagat, G., and Dalla-Favera, R. (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28-40
4. Calin, G. A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S. E., Shimizu, M., Taccioli, C., Zanesi, N., Garzon, R., Aqeilan, R. I., Alder, H., Volinia, S., Rassenti, L., Liu, X., Liu, C. G., Kipps, T. J., Negrini, M., and Croce, C. M. (2008) MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. U.S.A. 105, 5166-5171
5. Lia, M., Carette, A., Tang, H., Shen, Q., Mo, T., Bhagat, G., Dalla-Favera, R., and Klein, U. (2012) Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 119, 2981-2990
6. Michie, A. M., Nakagawa, R., and McCaig, A. M. (2007) Murine models for chronic lymphocytic leukaemia. Biochem. Soc. Trans. 35, 1009-1012
7. Phillips, J. A., Mehta, K., Fernandez, C., and Raveché, E. S. (1992) The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res. 52, 437-443
8. Raveche, E. S., Salerno, E., Scaglione, B. J., Manohar, V., Abbasi, F., Lin, Y. C., Fredrickson, T., Landgraf, P., Ramachandra, S., Huppi, K., Toro, J. R., Zenger, V. E., Metcalf, R. A., and Marti, G. E. (2007) Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109, 5079-5086
9. Salerno, E., Scaglione, B. J., Coffman, F. D., Brown, B. D., Baccarini, A., Fernandes, H., Marti, G., and Raveche, E. S. (2009) Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol. Cancer Ther. 8, 2684-2692
10. Salerno, E., Yuan, Y., Scaglione, B. J., Marti, G., Jankovic, A., Mazzella, F., Laurindo, M. F., Despres, D., Baskar, S., Rader, C., and Raveche, E. (2010) The New Zealand black mouse as a model for the development and pro- gression of chronic lymphocytic leukemia. Cytometry B Clin. Cytom. 78, S98-S109
11. Hardy, R. R., Kincade, P. W., and Dorshkind, K. (2007) The protean nature of cells in the B lymphocyte lineage. Immunity 26, 703-714
12. Hardy, R. R. (2006) B-1 B cell development. J. Immunol. 177, 2749-2754
13. Tamura, T., Yanai, H., Savitsky, D., and Taniguchi, T. (2008) The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535-584
14. De Silva, N. S., Simonetti, G., Heise, N., and Klein, U. (2012) The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev. 247, 73-92
15. Lu, R. (2008) Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 29, 487-492
16. Acquaviva, J., Chen, X., and Ren, R. (2008) IRF-4 functions as a tumor suppressor in early B-cell development. Blood 112, 3798-3806
17. Pathak, S., Ma, S., Trinh, L., Eudy, J., Wagner, K. U., Joshi, S. S., and Lu, R. (2011) IRF4 is a suppressor of c-Myc induced B cell leukemia. PLoSONE6, e22628
18. Shaffer, A. L., Emre, N. C., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., Zeng, Y., Chen, B., Epstein, J., and Staudt, L. M. (2008) IRF4 addiction in multiple myeloma. Nature 454, 226-231
19. Di Bernardo, M. C., Crowther-Swanepoel, D., Broderick, P., Webb, E., Sellick, G., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A. M., Sunter, N. J., Hall, A. G., Dyer, M. J., Matutes, E., Dearden, C., Mainou-Fowler, T., Jackson, G. H., Summerfield, G., Harris, R. J., Pettitt, A. R., Hillmen, P., Allsup, D. J., Bailey, J. R., Pratt, G., Pepper, C., Fegan, C., Allan, J. M., Catovsky, D., and Houlston, R. S. (2008) A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40, 1204-1210
20. Crowther-Swanepoel, D., Broderick, P., Ma, Y., Robertson, L., Pittman, A. M., Price, A., Twiss, P., Vijayakrishnan, J., Qureshi, M., Dyer, M. J., Matutes, E., Dearden, C., Catovsky, D., and Houlston, R. S. (2010) Finescale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum. Mol. Genet. 19, 1840-1845
21. Chang, C. C., Lorek, J., Sabath, D. E., Li, Y., Chitambar, C. R., Logan, B., Kampalath, B., and Cleveland, R. P. (2002) Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood 100, 4671-4675
22. Havelange, V., Pekarsky, Y., Nakamura, T., Palamarchuk, A., Alder, H., Rassenti, L., Kipps, T., and Croce, C. M. (2011) IRF4 mutations in chronic lymphocytic leukemia. Blood 118, 2827-2829
23. Mittrücker, H. W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., and Mak, T. W. (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543
24. Enzler, T., Kater, A. P., Zhang, W., Widhopf, G. F., 2nd, Chuang, H. Y., Lee, J., Avery, E., Croce, C. M., Karin, M., and Kipps, T. J. (2009) Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. Blood 114, 4469-4476
25. Ma, S., Turetsky, A., Trinh, L., and Lu, R. (2006) IFN regulatory factor 4 and 8 promote Ig light chain βlocus activation in pre-B cell development. J. Immunol. 177, 7898-7904
26. Burger, J. A., Ghia, P., Rosenwald, A., and Caligaris-Cappio, F. (2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 114, 3367-3375
27. Stevenson, F. K., Krysov, S., Davies, A. J., Steele, A. J., and Packham, G. (2011) B-cell receptor signaling in chronic lymphocytic leukemia. Blood 118, 4313-4320
28. Herling, M., Patel, K. A., Khalili, J., Schlette, E., Kobayashi, R., Medeiros, L. J., and Jones, D. (2006) TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 20, 280-285
29. Yan, X. J., Albesiano, E., Zanesi, N., Yancopoulos, S., Sawyer, A., Romano, E., Petlickovski, A., Efremov, D. G., Croce, C. M., and Chiorazzi, N. (2006) B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 103, 11713-11718
30. Laine, J., Künstle, G., Obata, T., Sha, M., and Noguchi, M. (2000) The protooncogene TCL1 is an Akt kinase coactivator. Mol. Cell 6, 395-407
31. Pekarsky, Y., Koval, A., Hallas, C., Bichi, R., Tresini, M., Malstrom, S., Russo, G., Tsichlis, P., and Croce, C. M. (2000) Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc. Natl. Acad. Sci. U.S.A. 97, 3028-3033
32. Stacchini, A., Aragno, M., Vallario, A., Alfarano, A., Circosta, P., Gottardi, D., Faldella, A., Rege-Cambrin, G., Thunberg, U., Nilsson, K., and Caligaris- Cappio, F. (1999) MEC1 and MEC2. Two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk. Res. 23, 127-136
33. Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655
34. Longo, P. G., Laurenti, L., Gobessi, S., Sica, S., Leone, G., and Efremov, D. G. (2008) The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 111, 846-855
35. Hofbauer, S. W., Piñón, J. D., Brachtl, G., Haginger, L., Wang, W., Jöhrer, K., Tinhofer, I., Hartmann, T. N., and Greil, R. (2010) Modifying Akt signaling in B-cell chronic lymphocytic leukemia cells. Cancer Res. 70, 7336-7344
36. Ghia, P., Chiorazzi, N., and Stamatopoulos, K. (2008) Microenvironmental influences in chronic lymphocytic leukaemia. The role of antigen stimulation. J. Intern. Med. 264, 549-562
37. Chiorazzi, N., Hatzi, K., and Albesiano, E. (2005) B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann. N.Y. Acad. Sci. 1062, 1-12
38. Pepper, C., Lin, T. T., Pratt, G., Hewamana, S., Brennan, P., Hiller, L., Hills, R., Ward, R., Starczynski, J., Austen, B., Hooper, L., Stankovic, T., and Fegan, C. (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 112, 3807-3817
39. Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C. G., Kipps, T. J., Negrini, M., and Croce, C. M. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 102, 13944-13949
40. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., and Reed, J. C. (1993) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820-1828
41. Nordgren, T. M., and Joshi, S. S. (2010) The etiology of chronic lymphocytic leukemia: another look at the relationship between B1 cells and CLL. Open Leukemia J. 3, 69-73
42. Sciammas, R., Shaffer, A. L., Schatz, J. H., Zhao, H., Staudt, L. M., and Singh, H. (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25, 225-236
43. Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K., and Dalla-Favera, R. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7, 773-782
44. Slager, S. L., Rabe, K. G., Achenbach, S. J., Vachon, C. M., Goldin, L. R., Strom, S. S., Lanasa, M. C., Spector, L. G., Rassenti, L. Z., Leis, J. F., Camp, N. J., Glenn, M., Kay, N. E., Cunningham, J. M., Hanson, C. A., Marti, G. E., Weinberg, J. B., Morrison, V. A., Link, B. K., Call, T. G., Caporaso, N. E., and Cerhan, J. R. (2011) Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 117, 1911-1916
45. Liu, H., Perlman, H., Pagliari, L. J., and Pope, R. M. (2001) Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-κB, Bad, or caspase activation. J. Exp. Med. 194, 113-126
46. Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., and Green, D. R. (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 21, 749-760
47. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321
48. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241
49. Jo, S. H., and Ren, R. (2012) IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner. J. Biol. Chem. 287, 1770-1778
50. Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., and Singh, H. (1996) Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10, 2335-2347
51. Negishi, H., Ohba, Y., Yanai, H., Takaoka, A., Honma, K., Yui, K., Matsuyama, T., Taniguchi, T., and Honda, K. (2005) Negative regulation of Tolllike- receptor signaling by IRF-4. Proc. Natl. Acad. Sci. U.S.A. 102, 15989-15994
52. Allan, J. M., Sunter, N. J., Bailey, J. R., Pettitt, A. R., Harris, R. J., Pepper, C., Fegan, C., Hall, A. G., Deignan, L., Bacon, C. M., Pointon, J. C., Houlston, R. S., Broderick, P., Mainou-Fowler, T., Jackson, G. H., Summerfield, G., Evans, P. A., Strefford, J. C., Parker, A., Oscier, D., Pratt, G., and Allsup, D. J. (2010) Variant IRF4/MUM1 associates with CD38 status and treatment- free survival in chronic lymphocytic leukaemia. Leukemia 24, 877-881